Actively Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
Led by Montreal Heart Institute · Updated on 2025-10-09
21000
Participants Needed
15
Research Sites
260 weeks
Total Duration
On this page
Sponsors
M
Montreal Heart Institute
Lead Sponsor
C
Centre Hospitalier Universitaire de Bordeaux, FRANCE
Collaborating Sponsor
AI-Summary
What this Trial Is About
This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.
CONDITIONS
Official Title
Enhanced Valves Interventions and Safe AI Generated End Results
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have reached the legal age of majority under local laws
- For TAVI group: Patients who had TAVI with a third generation transcatheter heart valve and have an optimal quality pre-procedural CT scan meeting specific imaging parameters
- For TMVI group: Patients who had TMVI with a dedicated device and have an optimal quality CT scan
- For TTVI group: Patients who had TTVI with a dedicated device and have an optimal quality CT scan
- For M-TEER group: Patients who had M-TEER with G4 or newer MitraClip or G2 or newer Pascal, with available pre-procedural TEE video images from Phillips or GE showing clear mitral valve views, at least 40 frames per second, and acceptable 3D reconstructions
- For T-TEER group: Patients who had T-TEER with G4 or newer TriClip or G2 or newer Pascal, with available pre-procedural TEE video images from Phillips or GE showing clear tricuspid valve views, at least 40 frames per second, and acceptable 3D reconstructions including transgastric images
You will not qualify if you...
- For TAVI group: Valve-in-valve procedures
- For TMVI group: Valve-in-valve and valve-in-ring procedures
- For TTVI group: Valve-in-valve and valve-in-ring procedures
- For M-TEER group: Use of G3 or older MitraClip or G1 Pascal devices
- For T-TEER group: Use of G3 TriClip or G1 Pascal devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
Montefiore Medical Center New York
New York, New York, United States, 10467
Actively Recruiting
2
Montreal Heart Institute, 5000 Rue Bélanger, Montréal
Montreal, Quebec, Canada, H1T 1C8
Actively Recruiting
3
St Michael's Hospital Toronto
Toronto, Canada
Actively Recruiting
4
St Paul's Hospital Vancouver
Vancouver, Canada
Actively Recruiting
5
Centre Hospitalier Universitaire (CHU) de Bordeaux, 12 rue Dubernat 33404 Talence cedex
Bourdeaux, France, 33404
Actively Recruiting
6
CHU Lille
Lille, France
Actively Recruiting
7
CHU Marseille
Marseille, France
Actively Recruiting
8
Centre Cardiologique du Nord Paris
Paris, France
Actively Recruiting
9
Institut Cardiovasculaire Paris-Sud Paris
Paris, France
Actively Recruiting
10
Centre Hospitalier Universitaire Rennes
Rennes, France
Actively Recruiting
11
Clinque Pasteur Toulouse - France
Toulouse, France
Actively Recruiting
12
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Actively Recruiting
13
Heart Valve Center Mainz
Mainz, Germany
Actively Recruiting
14
Istituto Clinico Città di Brescia
Brescia, Italy
Actively Recruiting
15
San Raffaele Heart Valve Center Milan
Milan, Italy
Actively Recruiting
Research Team
T
Thomas Modine, MD, PhD
CONTACT
W
Walid Ben Ali, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here